CVS HEALTH Corp
—Price / book
Market cap
—
Tangible equity (USD)
-$35.77B
Price / tangible book
—
Price / book
—
Net income / ending equity
2.4%
Net income / ending assets
0.7%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CVS stock price vs HRB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HRB's multiple
Needs HRB P/E.
Implied fair value · at CVS's multiple
Needs CVS P/E.
Price unavailable
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
19 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity (USD)
-$35.77B
Price / tangible book
—
Price / book
—
Net income / ending equity
2.4%
Net income / ending assets
0.7%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity (USD)
-$962.04M
Price / tangible book
—
Price / book
—
Net income / ending equity
624.4%
Net income / ending assets
22.5%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CVS HEALTH Corp · implied price per share
Bear
$43.35
Base
$58.49
Bull
$78.21
H&R Block, Inc. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Walgreens Boots Alliance, Inc.
CVS vs WBA
UNITEDHEALTH GROUP INC
CVS vs UNH
Walmart Inc.
CVS vs WMT
Cigna Group
CVS vs CI
HUMANA INC
CVS vs HUM
Elevance Health, Inc.
CVS vs ELV
INTUIT INC.
CVS vs INTU
AUTOMATIC DATA PROCESSING INC
CVS vs ADP
PAYCHEX INC
CVS vs PAYX
Block, Inc.
CVS vs SQ
Blucora, Inc.
CVS vs BCOR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CVS can materially expand margins and sustain much faster earnings growth than HRB, then hold or add despite the valuation gap because the current price already implies a very large de-rating; otherwise, the data favor avoiding CVS on a relative valuation basis because its P/E is far above HRB's while profitability and leverage are weaker.
The valuation gap is extreme: CVS trades at 75.8x P/E versus HRB at 10.3x, yet the P/E-based implied price is only $14.31 versus CVS's current $105.37. That suggests the stock is far above HRB-derived valuation anchor and well outside the lower end of its historical band.
Supporting Metrics